EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.4.1.87 | Breast Neoplasms |
15987454 |
Designing a HER2/neu promoter to drive alpha1,3galactosyltransferase expression for targeted anti-alphaGal antibody-mediated tumor cell killing. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 2.4.1.87 | Carcinogenesis |
6403518 |
Enzymatic basis for changes in fucoganglioside during chemical carcinogenesis. Induction of a specific alpha-fucosyltransferase and status of an alpha-galactosyltransferase in precancerous rat liver and hepatoma. |
ongoing research
therapeutic application
unassigned |
3
1
0 |
| 2.4.1.87 | Carcinoma, Ehrlich Tumor |
6787040 |
An alpha-D-galactosyltransferase activity in Ehrlich ascites tumor cells. Biosynthesis and characterization of a trisaccharide (alpha-D-galactose-(1 goes to 3)-N-acetyllactosamine). |
ongoing research
unassigned |
2
0 |
| 2.4.1.87 | Carcinoma, Embryonal |
8621726 |
Transcriptional regulation of alpha1,3-galactosyltransferase in embryonal carcinoma cells by retinoic acid. Masking of Lewis X antigens by alpha-galactosylation. |
unassigned |
0 |
| 2.4.1.87 | Carcinoma, Hepatocellular |
6403518 |
Enzymatic basis for changes in fucoganglioside during chemical carcinogenesis. Induction of a specific alpha-fucosyltransferase and status of an alpha-galactosyltransferase in precancerous rat liver and hepatoma. |
ongoing research
therapeutic application
unassigned |
3
1
0 |
| 2.4.1.87 | Lymphoma |
6438103 |
Enzymatic and organizational difference in expression of a Burkitt lymphoma-associated antigen (globotriaosylceramide) in Burkitt lymphoma and lymphoblastoid cell lines. |
unassigned |
0 |
| 2.4.1.87 | Lymphoma |
15921377 |
Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells. |
ongoing research
therapeutic application
unassigned |
4
2
0 |
| 2.4.1.87 | Melanoma |
9000578 |
Reduction of metastatic properties of BL6 melanoma cells expressing terminal fucose(alpha)1-2-galactose after alpha1,2-fucosyltransferase cDNA transfection. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
2
1 |
| 2.4.1.87 | Melanoma |
9703870 |
Eliciting hyperacute xenograft response to treat human cancer: alpha(1,3) galactosyltransferase gene therapy. |
causal interaction
ongoing research
therapeutic application
unassigned |
1
4
3
0 |
| 2.4.1.87 | Melanoma |
10416604 |
Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
4
2
0 |
